Evaluation of Duodenal Mucosal Resurfacing in Subjects With Type 2 Diabetes

Safety and Feasibility of Novel Therapy for Duodenal Mucosal Regeneration for Type II Diabetes

NCT05014204 ·Status: COMPLETED ·Phase: NA

Evaluation of the Impact of Intensive Short-Term Drug Therapy in Patients With Type 2 Diabetes Mellitus

NCT04027023 ·Status: UNKNOWN ·Phase: PHASE4

Study of Duodenal Mucosal RF Vapor Ablation in Subjects With Type-2 Diabetes Mellitus

NCT05887635 ·Status: RECRUITING ·Phase: NA

RF Vapor Ablation Retreatment of Duodenal Mucosa in Non-responders With Type-2 Diabetes Mellitus

NCT06724822 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Does the Hematopoietic Stem Cell Govern Residual Inflammatory Cardiovascular Risk in Type 2 Diabetes

NCT05597202 ·Status: UNKNOWN ·Phase: PHASE4

Study Evaluating the Safety and Feasibility of Endoscopic Duodenal Injections of Autologous Mesenchymal Stem Cells

NCT07344324 ·Status: NOT_YET_RECRUITING ·Phase: NA

Evaluation of the Efficacy of Intramuscular Islet Autograft After Extensive Pancreatectomy

NCT02872571 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

Normalization of Fasting Glucose and the Incidence of Restenosis After Peripheral Angioplasty

NCT01150617 ·Status: TERMINATED ·Phase: PHASE4

Human Islet Transplantation in Brittle Type 1 Diabetes Mellitus. The GRAGIL 2 Study.

NCT00321256 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Role of Endoplasmic Reticulum Stress in the Pathophysiology of Type 2 Diabetes

NCT02368704 ·Status: UNKNOWN

Effect of Glucagon-like Peptide 2 on Gallbladder Motility After a Meal in Young, Healthy Male Subjects

NCT03682172 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Effects of Empagliflozin on Liver Fat Content, Energy Metabolism and Body Composition in Patients With Type 2 Diabetes

NCT02637973 ·Status: COMPLETED ·Phase: PHASE4

Monocyte Function and Inflammation in Type 1 Diabetes and Its Modulation

NCT00441844 ·Status: COMPLETED ·Phase: PHASE2

Clinical Study for Dimethyl Fumarate in Preserving Islet β-Cell Function in Type 1 Diabetes Mellitus

NCT07258394 ·Status: RECRUITING ·Phase: PHASE3

The Effect of Anakinra on Insulin Secretion

NCT01285232 ·Status: UNKNOWN ·Phase: NA

The Impact of Glucose Lowering Therapies on Circulating Endothelial Progenitor Cells and Its Mobilising Factor Stromal Derived Factor-1α in Patients With Type 2 Diabetes

NCT02694575 ·Status: COMPLETED

New Imaging Procedure for the Localisation of Insulinoma

NCT02127541 ·Status: COMPLETED ·Phase: NA

Effect of Dulaglutide on Glycemic Variability in Patients With Type 2 Diabetes

NCT04374578 ·Status: COMPLETED

Effect of Fasting Therapy on Blood Glucose Control and Islet Function in Newly Diagnosed Type 2 Diabetic Patients

NCT02956655 ·Status: UNKNOWN ·Phase: NA

Duodenal Exclusion for the Treatment of Type 2 Diabetes

NCT00534547 ·Status: WITHDRAWN ·Phase: NA

A Study to Assess the Effect of Creon® on Pancreatic Exocrine Insufficiency in Subjects With Diabetes Mellitus Type 2

NCT02009410 ·Status: WITHDRAWN ·Phase: PHASE4

Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes

NCT06267391 ·Status: RECRUITING ·Phase: NA

Effect of Novel Glucagon Receptor Antagonist REMD-477 on Glucose and Adipocyte Metabolism in T2DM

NCT05093517 ·Status: COMPLETED ·Phase: EARLY_PHASE1

The Role of Small Intestinal Endocrine Cells in Type 2 Diabetic Hyperglucagonemia

NCT00639613 ·Status: COMPLETED

Effect of Metformin and Cholecystokinin-mediated Gallbladder Emptying on GLP-1 Secretion in Type 2 Diabetes

NCT02497313 ·Status: COMPLETED ·Phase: NA